Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1-Deficient Malignant Pleural Mesothelioma: A Randomized Clinical Trial.

JAMA oncology2017Szlosarek PW, Steele JP, Nolan L, et al.

Scholarly article — Clinical Trial, Phase II / Journal Article / Multicenter Study / Randomized Controlled Trial

Study designRandomized controlled trial

SubjectHuman

Record checks

Study design: Randomized controlled trial
Subject: Human
Publication year: 2017
Source: doi.org
Abstract display: Not reproduced here
Publication status: Active
Status checked: 17 Aug 2026
Collected: 13 Aug 2026
Freshness: Current
Review stage: Automated
Record status: Published

How to read this record →

Abstract

The abstract is not reproduced here. Please consult the original source.

MeSH

AgedAged, 80 and overArginineArgininosuccinate SynthaseBiomarkers, TumorCitrullinemiaDNA MethylationDisease-Free SurvivalEndpoint DeterminationFemaleHumansHydrolasesLung NeoplasmsMaleMesotheliomaMesothelioma, MalignantMiddle AgedPolyethylene GlycolsTreatment Outcome

DOI 10.1001/jamaoncol.2016.3049

PMID 27584578

View source →